For US Healthcare Professionals Only
Filter
Impact of prolonged seizures on patients’ and caregivers’ quality of life
Experiences of women of childbearing age with epilepsy throughout their motherhood journey: results from a social media listening study
Safety, tolerability, pharmacokinetics, and efficacy of fenfluramine in combination with cannabidiol: results from an exploratory phase 1 study
Safety and effectiveness of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: results from the final analysis of an open-label extension study
Interim results of the US fenfluramine oral solution cardiovascular safety registry study
A stratified analysis of efficacy and safety of fenfluramine in patients with Dravet syndrome
Real world use of fenfluramine for Dravet syndrome: a retrospective cohort study using a national pharmacy database
Impact of fenfluramine on convulsive seizure frequency in dose-capped patients with Dravet syndrome
Sleep apnea is associated with high mortality risk in children with severe epilepsies: an observational analysis from large scale US claims data
Brivaracetam monotherapy patient characteristics, treatment patterns, and healthcare resource utilization among patients with epilepsy: a cohort study using US claims data
Correlation between MG Symptoms PRO and existing MG‑specific outcome scores in the Phase 3 MycarinG study: Post hoc analysis
A retrospective claims study evaluating mortality in patients with Lennox-Gastaut or Dravet syndrome in the United States
Disruptive impacts of developmental and epileptic encephalopathies on patient and family life: a quality-of-life survey
Understanding the incidence, prevalence, characteristics, and healthcare resource utilization for patients with Dravet and Lennox-Gastaut syndromes
Long-term tolerability and efficacy of adjunctive brivaracetam in pediatric patients with primary generalized seizures: subgroup analysis of an open-label, follow-up trial
Effect of zilucoplan on myasthenia gravis-specific outcome subdomain scores in RAISE: A Phase 3 study
Solutions to address the unmet needs of the gMG patient journey in the US: A multistakeholder Delphi consensus study
A Novel International Patient Registry in Myasthenia Gravis Linking Clinical and Patient-Reported Outcomes Data: The Vitaccess Real MG (VRMG) Registry
Effect of rozanolixizumab on ocular symptoms in patients with generalized myasthenia gravis: A post hoc item-level analysis of myasthenia gravis-specific outcomes in MycarinG
Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in myasthenia gravis: Patient preference and satisfaction from a Phase 3b study
Self-administration of rozanolixizumab in patients with generalized myasthenia gravis: The MG0020 study